Virology & Vaccine Research

Antibody Solutions for Viral Research and Vaccine Development

Validated antibodies and custom reagents for studying emerging and established viral threats—including SARS-CoV-2, influenza, and more.

The pace of virology research demands precise, reliable reagents. ProSci offers high-performance antibodies and custom antibody services to support immune response studies, viral protein detection, and vaccine development workflows. Whether you’re developing new vaccines, testing viral diagnostics, or conducting epidemiological surveillance, we provide tools that make your research stronger. 

What We Offer

Tailored antibody solutions for the unique needs of your field.
Explore how ProSci supports your research, development, and production goals.

Targeted Coverage for Key Viruses

  • SARS-CoV-2 (Spike, Nucleocapsid, etc.)
  • Influenza A/B, RSV, Dengue, Zika, Ebola, HIV, HCV, and more
  • Tools for both human and zoonotic virus research 

Validated for Research Applications

  • ELISA, Western blot, IHC, flow cytometry, and neutralization assays
  • Ideal for immunogenicity testing, challenge models, and serological screening

Custom Antibody Development

  • Polyclonal and monoclonal production tailored to viral proteins
  • Anti-idiotypic and neutralizing antibody options
  • Mouse monoclonal packages available for assay optimization

Why Choose ProSci

Speed & Flexibility

Rapid turnaround to support time-sensitive viral studies

Scientific Rigor

Antibodies validated against relevant viral proteins

Experienced Team

Supporting vaccine and infectious disease researchers for decades

Catalog Depth

Ready-to-use antibodies for immediate deployment

Use Cases

Looking for a Partner to Support Your Antibody Discovery Needs?

 Or browse our viral research reagent catalog